血管内冲击波（IVL）技术凭借在血管内钙化病变治疗中的突破性价值，已成为全球医疗器械领域的热点赛道。在此背景下，国内 IVL 企业加速崛起。近两年，国产 IVL 产品获批进程显著提速，截至目前已有 9 款产品成功上市，多家企业已启动或即将开启出海征程。

ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...

As we move towards year-end 2023, I am assembling a list of potential healthcare tickers that are worthy of consideration for a spot in one of my three healthcare portfolios (speculative, growth, ...